Cancer Research

Why Are Rural ERs Operating Without On-Site Doctors?
Research & Development Why Are Rural ERs Operating Without On-Site Doctors?

Imagine a small town in rural America, where the nearest hospital is the only lifeline for emergencies, yet no doctor is present when a critical situation unfolds, leaving patients at risk. This scenario is becoming alarmingly common as rural emergency rooms (ERs) across the U.S. increasingly

3D-Printed Kidney Tumors Revolutionize Cancer Treatment
Research & Development 3D-Printed Kidney Tumors Revolutionize Cancer Treatment

What if a doctor could test life-saving cancer treatments on an exact copy of a patient’s tumor before ever prescribing a drug? This revolutionary concept is no longer confined to science fiction but is becoming a tangible reality through the advent of 3D-printed kidney tumor organoids. These

Sartorius Invests $3M in Nanotein for Cell Therapy Innovation
Research & Development Sartorius Invests $3M in Nanotein for Cell Therapy Innovation

In a landscape where medical breakthroughs are increasingly vital to combat complex diseases, a significant development has emerged in the life sciences sector with Sartorius Stedim Biotech’s recent $3 million investment in Nanotein Technologies, a US-based biotech startup. This company specializes

Novel MET Inhibition Boosts Immunotherapy for Lung Cancer
Research & Development Novel MET Inhibition Boosts Immunotherapy for Lung Cancer

Small cell lung cancer (SCLC) represents one of the most formidable challenges in oncology, characterized by its aggressive nature and a disheartening prognosis that leaves many patients with limited hope. Accounting for roughly 15% of lung cancer cases, this disease spreads rapidly and often

Can mRNA Vaccines Revolutionize Gastric Cancer Treatment?
Tech & Innovation Can mRNA Vaccines Revolutionize Gastric Cancer Treatment?

Imagine a world where a tailored vaccine could strike at the heart of one of the deadliest cancers with unmatched precision, offering hope to countless patients battling a grim prognosis. Gastric cancer ranks among the leading causes of cancer-related deaths globally, often recurring in a

IO Biotech's Cylembio Shows Promise Despite Trial Setback
Research & Development IO Biotech's Cylembio Shows Promise Despite Trial Setback

Imagine a world where melanoma, one of the deadliest forms of skin cancer, could be tackled with a groundbreaking vaccine that boosts existing treatments for patients who currently have limited options. This scenario lies at the heart of recent discussions surrounding IO Biotech's experimental

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later